ISL
AGN

Ingalls & Snyder LLC’s Allergan plc AGN Stock Holding History

Ingalls & Snyder LLC’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7,003
Closed -$1.24M – 440
2020
Q1 		$1.24M Sell
7,003
-56
-0.8% -$10.5K 0.08% 171
2019
Q4 		$1.35M Sell
7,059
-100
-1% -$18K 0.07% 169
2019
Q3 		$1.21M Buy
+7,159
New +$1.17M 0.06% 194
2017
Q4 		– Sell
-1,408
Closed -$289K – 424
2017
Q3 		$289K Buy
1,408
+104
+8% +$24.2K 0.02% 295
2017
Q2 		$317K Buy
1,304
+50
+4% +$11.7K 0.02% 287
2017
Q1 		$300K Buy
1,254
+214
+21% +$49.8K 0.02% 313
2016
Q4 		$218K Sell
1,040
-320
-24% -$66.3K 0.01% 362
2016
Q3 		$313K Buy
1,360
+100
+8% +$24.4K 0.02% 307
2016
Q2 		$291K Buy
1,260
+350
+38% +$80.7K 0.02% 323
2016
Q1 		$243K Hold
910
– – 0.02% 306
2015
Q4 		$284K Hold
910
– – 0.02% 296
2015
Q3 		$247K Hold
910
– – 0.02% 302
2015
Q2 		$276K Hold
910
– – 0.02% 302
2015
Q1 		$270K Buy
+910
New +$259K 0.01% 305

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Ingalls & Snyder LLC's AGN Position: Q2 2020 in Review

Ingalls & Snyder LLC sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 7,003 shares — an estimated $1.24M sold.

Ingalls & Snyder LLC first reported a position in AGN in Q1 2015 and held it in 14 quarters. The position peaked at $1.35M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Ingalls & Snyder LLC reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Ingalls & Snyder LLC sold 7,003 Allergan plc shares in Q2 2020, an estimated $1.24M.
  • Ingalls & Snyder LLC first reported a position in Allergan plc in Q1 2015 and held it in 14 quarters.
  • Ingalls & Snyder LLC's Allergan plc position peaked at $1.35M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Ingalls & Snyder LLC's 13F filing for Q2 2020, filed 31 Jul 2020.